Other languages Pharma Equity Group A/S

Equities

PEG A

DK0061155009

Market Closed - Nasdaq Copenhagen Other stock markets 08:53:01 2024-05-02 am EDT			5-day change	1st Jan Change
0.246 ^DKK	+2.50%		-6.11%	-42.79%

Apr. 10	Pharma Equity Group A/S announced that it has received DKK 7.6 million in funding	CI
Apr. 05	Pharma Equity Group?s subsidiary, Reponex Pharmaceuticals A/S, reports highly positive final results from the phase-2 clinical trial of the company?s patented drug candidate RNX-051	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Pharma Equity Group?s subsidiary, Reponex Pharmaceuticals A/S, reports highly positive final results from the phase-2 clinical trial of the company?s patented drug candidate RNX-051	Apr. 05
Pharma Equity Group A/S Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 20
Pharma Equity Group A/S Provides Group Earnings Guidance for the Full Year 2024	Mar. 20
Pharma Equity Group's Subsidiary (Reponex Pharmaceuticals A/S) Receives Notification from the European Patent Office	Jan. 22
Pharma Equity Group A/S Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Jan. 17
Pharma Equity Group Unit Meets Primary Endpoints in Colon Cancer Treatment Trial	Nov. 16
Pharma Equity Group A/S Announces Positive Preliminary Results from the Phase-2 Clinical Trial	Nov. 16
Pharma Equity Group A/S Approves Board Appointments	Nov. 02
Pharma Equity Group?S Subsidiary Company Reponex Pharmaceuticals A/S Receives Grant of Us Patent for A Method of Treatment on Its Topical Wound-Healing Composition	23-10-31
Pharma Equity Group A/S Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-16
Reponex Pharmaceuticals Set for US Patent for Chronic Wound Treatment Method	23-08-15
Pharma Equity Group A/S Announces Board Changes	23-06-15
Reponex Pharmaceuticals A/S Announces CEO Changes	23-06-14
Reponex Pharmaceuticals A/S Names Dr Christopher M Burton MD, PhD as Chief Medical Officer	23-06-14
Pharma Equity Group A/S Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-10
Pharma Equity Group A/S Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-10
Pharma Equity Group A/S Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-31
Reponex Pharmaceuticals A/S completed the acquisition of Pharma Equity Group A/S.	23-03-23
Rolls-Royce : Turquoise Yachts commande un mtu hybride	22-09-28
Blue Vision A/S Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-31

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Pharma Equity Group A/S

Equities

PEG A

DK0061155009

Other languages

Filters